Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Robot Therapy Tipping Point: Caveats for Post hoc Speculation.
Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study.
[Diagnosis and differential diagnosis of demyelinating optic neuropathy in multiple sclerosis.]
Non pharmacological interventions for spasticity in multiple sclerosis.
Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis.
Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Newer multiple sclerosis drugs and disability scores - are key data analyses missing?
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis.
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study.
[Molecular targeted therapy for neuroimmunological diseases].
Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury.
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats.
CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation.
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments.
Helicobacter pylori and autoimmune disease: Cause or bystander.
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.
A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo.
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
Quantitative proteome profiling of CNS-infiltrating autoreactive CD4(+) cells reveals selective changes during experimental autoimmune encephalomyelitis.
Autologous bone marrow transplantation for the treatment of multiple sclerosis.
Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
Chemokine receptor expression by inflammatory T cells in EAE.
CRYAB-650 C>G (rs2234702) affects susceptibility to Type 1 diabetes and IAA-positivity in Swedish population.
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.

Pages